RxDoctor Payments Data

William Craig, MD

Interventional Cardiology · Joplin, MONPI 1831130020

Payments from drug & device makers

$1,920in general payments, 2019–2025

Across 90 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$516
  • E.r. Squibb & Sons, L.L.C.$351
  • Shockwave Medical, Inc$119
  • Philips North America LLC$107
  • Abbott$105
  • Boston Scientific$104
  • plus $618 from 15 others

What the payments were for

  • Food & beverage$1,920100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,920 in reported general payments places this provider in the 10th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri

Medicare billing

Part B allowed, 2024
$215,741
Medicare patients
1,832
Services billed
3,638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban367$332,480
EntrestoSacubitril/Valsartan55$65,273
Repatha SureclickEvolocumab83$64,324
XareltoRivaroxaban73$61,315
JardianceEmpagliflozin19$23,305
Repatha SyringeEvolocumab26$14,469
Praluent PenAlirocumab17$11,984
BrilintaTicagrelor17$7,736
Metoprolol Succinate684$6,650
Ranolazine ErRanolazine60$4,300
Atorvastatin Calcium630$4,007
ClopidogrelClopidogrel Bisulfate588$3,736
Diltiazem 24hr Er (Cd)Diltiazem Hcl112$2,748
Losartan Potassium298$2,603
Carvedilol424$2,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$95$332,480367 claims
NovartisEntresto$87$65,27355 claims
Johnson & JohnsonXarelto$13$61,31573 claims
Boehringer IngelheimJardiance$59$23,30519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 182 interventional cardiology providers in Missouri.

Other interventional cardiology in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →